- Equifax Inc's (NYSE:EFX) price target has been lowered to $300 (an upside of 26%) from $330 by Barclays analyst Manav Patnaik.
- The analyst maintained his Overweight rating on EFX's shares.
- Patnaik's price target reduction mirrors market de-rating and the recession risk.
- Meanwhile, the analyst appreciates the diversity of the company's solution sets and tech-powered innovation capabilities.
- Yesterday, Morgan Stanley lowered its price target on Equifax to $274 (an upside of 16%) from $296 while maintaining the Overweight rating on the shares.
- Also Read: Equifax, Team Velocity Partner On Marketing Solutions For Auto Dealers
- Price Action: EFX shares traded higher by 1.80% at $238.03 on the last check Thursday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Barclays Cuts Equifax's Price Target By 9%
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks